The Division of Gastroenterology and Hepatology hosts30faculty members dedicated to clinical practice, research and education. Our division trains 15 fellows at a steady state, 4 of whom are funded by NIH research training grants. We are NIH funded to train clinical psychology students to specialize in the psychosocial aspects of digestive disorders and the brain-gut connection.
With approximately $4 million in sponsored research and a rapidly growing portfolio, the Division of Gastroenterology and Hepatology investigates esophageal and motility disorders including achalasia, dysphagia, and GERD, as well as areas of interventional GI and pancreaticobiliary diseases, quality improvement, and psychosocial GI. We also host several industry-sponsored clinical trials, especially in the areas of Hepatitis C, NASH, eosinophilic esophagitis and inflammatory bowel diseases.
In addition to general GI and Hepatology care, Divison faculty offer specialty, multidisciplinary care in the areas of achalasia, bariatrics, eosinophilic esophagitis, scleroderma, defecatory disorders, NASH, liver transplant, nutrition, and health psychology.Through Northwestern Medicine facilities, division faculty delivers approximately 14,000 annual patient visits.
Strength | 40 mg |
Packaging Size | 10*15 Tablets |
Packaging Type | Strips |
Composition | Esomeprazole 40 mg |
Brand Name | SOMPRAZ 40 |
Manufacturer | SUN PHARMA |
Shelf Life | 24 Months |
Prescription/Non-Prescription | Prescription |
Country of Origin | Made in India |
Sompraz 40 Tablet is used to treat conditions related to excessive stomach acid production, such as gastroesophageal reflux disease (GERD), peptic ulcer disease, and Zollinger-Ellison syndrome. It reduces the amount of acid produced in the stomach and provides relief from symptoms and promotes healing. |